Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.4 USD | +2.20% | +0.90% | +19.59% |
02/05 | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,761 GBX | +1.59% | +5.26% | 88.87B | ||
162.5 DKK | +1.66% | +5.86% | 1.8B | ||
148.7 USD | +0.09% | +2.86% | 358B | ||
91.88 EUR | +0.94% | -1.29% | 122B | ||
3.02 USD | +0.67% | +7.47% | 24.35M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.59% | 323B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B | |
-3.54% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck and : Why the world needs more than one Ebola vaccine